Ladies and gentlemen, welcome to the Comet Full Year 2025 Results Conference Call and live webcast. I am Sandra, the conference call operator. I would like to remind you that all participants are in listen only mode and the conference is being recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star one on your telephone. For operator assistance, please press star zero. The conference must not be recorded for publication or broadcast. At this time, it is my pleasure to hand over to Ulrich Steiner, VP Investor Relations. He will now be joined into the conference room. Good afternoon, ladies and gentlemen. Welcome to Comet's Full Year 2025 Results presentation here in Zurich. Also welcome to those following us over the webcast or in the conference call. Today with me, for the results are our CEO, Stephan Haferl, and our CFO, Christian Witt. Before we start with the presentation, as usual, we will make some forward-looking statements that probably do not reflect the development during the year. Please note and read the disclaimer. After the presentations given by the gentleman, you will have the possibility to ask questions. With that, I'll hand over to Stephan for his part. Thank you, Uli. Ladies and gentlemen, welcome to Comet's Full Year 2025 Result presentation. We appreciate you taking the time to join us today, whether you're here in person or in the webcast. Before our CFO, Christian Witt, walks you through the financials, I would like to take a moment to see and set the scene by outlining the broader macroeconomic environment and the key industry developments that shaped our performance over the year. 2025 was a year of progress. Financially, it was below our expectations at the beginning of the year, but it allowed us to prepare well for the next phase of the semiconductor investment cycle. In a highly volatile and unpredictable market environment, we still delivered top-line growth of 2.6% year-on-year. This reported growth was thereby significantly impacted by foreign exchange movements, in particular by the weak U.S. dollar against the Swiss franc. Excluding the currency effects, our underlying performance becomes clearer. On a constant currency basis, sales grew by 7.3%, reflecting solid demand for our solutions and the strength of our positioning with customers. Turning to profitability, EBITDA came in below the prior year. This was driven in part by the same currency headwinds, but also by product and regional mix effects, and by our investment into future growth. These strategic investments aim at strengthening our products and platforms, expanding capacity, and preparing the company for the next growth phase. The operating environment in which we found ourselves in 2025 was marked by elevated volatility and limited visibility. Geopolitical tensions and trade barriers caused customers to delay or face investments and for us to hold and postpone shipments. What did this mean for us? First, we refined and adapted our strategy to reflect these realities. We sharpened our focus, reprioritized certain initiatives, and added targeted elements to our strategy to strengthen execution and resilience. I will come back to this point later. Second, and importantly, we made tangible operational progress. In 2025, we secured our first high volume orders for Synertia with momentum continuing to build. Also, we booked several repeat orders for our CA20 X-Ray Systems, moving from development and qualification into the market. These developments lay the foundation for scalable growth in the coming years and reinforce our confidence in the long-term potential of our portfolio. In parallel, our most important infrastructure as well as transformation project, the new site in Penang, Malaysia remains fully on track. The handover took place just a few weeks ago. We expect the site to become operational in the second half of 2026, supporting both growth and efficiency as volumes increase. To summarize, while we are not fully satisfied with our overall performance in 2025, we have made meaningful progress in positioning the company for the next phase of growth. This brings me to the market environment we are seeing today, which is defined by two parallel dynamics: AI-driven structural growth in semiconductors and a selective uneven recovery across industrial markets. AI demand is no longer incremental. It is shaping, reshaping the semiconductor industry. It is, so to say, the main show. This is most visible in wafer fabrication equipment with spending focused on AI-critical logic and advanced memory. Within a memory, the recovery is also uneven. DRAM outperforms NAND for now, driven by strong demand for high bandwidth memory used in AI accelerators. Tight supply conditions have supported pricing and therefore improved in industry profitability. NAND, by contrast, is recovering more gradually, reflecting still weaker although also growing demand. This divergence in end market strength has directly influenced investment behavior across the industry, even with a disciplined approach centered on optimizing existing capacity rather than expanding it. Total wafer fab equipment CapEx grew by approximately 11% year-over-year in fiscal 2025. In the broader industrial landscape, activity is stabilizing with multiple indicators pointing to a bottoming process. The recovery remains, however, uneven. Automotive and EV related semiconductor and battery demand continues to be soft. At the same time, we are seeing strong growth in non-destructive testing demand from the aerospace and defense sectors. Overall, the operating environment remains complex. Trade restrictions and tariffs are contributing to elevated uncertainty and pressure on margins. Meanwhile, government infrastructure programs provide selective support, though their impact varies by region and also application. With this market context in mind, let me outline the key milestones achieved across our divisions in 2025, starting with the division PCT. Now, PCT is benefiting from increased exposure to the AI market, which is driving meaningful growth opportunities. This higher AI exposure p ositions PCT well to capitalize on the expanding demand for advanced technologies. However, it is important to note that the benefits from recent upgrades have been limited to date. We view this as a temporary phase, with the upside largely deferred to the evolving investment cycle. Our pipeline remains robust and on track, highlighted by Synertia's high volume manufacturing orders received towards the end of 2025 and continuing into 2026. These orders represent a significant milestone for us. In preparation for the growth ahead, our Penang facility startup is also progressing well. We are making solid advancements in supply chain readiness and operational efficiency to ensure we can meet the anticipated increase in demand in the coming years. At IXS, the first commercial sales of our CA20 systems were achieved in the second half of 2025. This milestone marks a significant step forward in bringing our innovative solutions to market and validates the strength of our technology in real world applications. To support this momentum, we have increased our investment in go to market efforts for the CA20 platform. We are expanding our range to better meet customer needs and accelerate adoption across key segments. In addition, IXS has been selected as a partner in the so-called Joint Three program, enabling us to leverage shared expertise and resources to accelerate further CA20's development and market penetration. To sharpen our strategic focus on the semiconductor sector, we are undertaking a restructuring within IXS. This transformation is designed to streamline operations, enhance agility and concentrate our efforts on high impact opportunities within the semiconductor space. In the IXM division, our new core platforms are now fully production ready, marking a critical milestone that enables us to meet growing customer demand with confidence and reliability. This preparedness is underpinned by the successful commissioning of our new clean room facility in Switzerland, in Flamatt, significantly strengthening our manufacturing capabilities at IXM. We have also improved the speed from R&D to production, allowing us to bring innovations to market more rapidly, ultimately strengthening our competitive position. In terms of market presence, IXM has achieved meaningful market share gains in both the U.S. And China. Importantly, we have successfully managed the tariff burden, mitigating its impact on our cost structure and pricing competitiveness. Together, these advancements position IXM for sustained growth and enhanced value creation. Let me summarize 2025. In the semiconductor market, recovery is progressing but at different speeds. Within this environment, the key memory segment is still experiencing slower growth, but is expected to accelerate over the next few quarters as volume markets pick up again, increasing the need for higher production capacities. While industrial activity remains subdued and competition intense in parts of the business, our X-Ray divisions are responding with focused execution and enhanced differentiation. These actions position us well to manage pricing dynamics and benefit from improving order momentum over time. At the same time, we are making tangible progress in Synertia commercialization for PCT, moving steadily from qualification into broader market adoption. This represents an important strategic milestone and a meaningful growth opportunity as we scale. In X-Ray Systems, profitability remains weak. However, this is a deliberate choice as we are prioritizing targeted growth investments to strengthen our technology position and expand future addressable markets. While this impacts near-term margins, we believe it is the right decision to unlock long-term value. By contrast, X-Ray Modules continues to demonstrate solid performance, even in softer end markets. Execution has been strong, cost discipline is evident, and the business is delivering resilient results despite external headwinds. In summary, 2025 was about positioning rather than peak performance. We were operating in mixed market conditions, we made intentional choices, investing where we see profitable growth and advancing key commercialization initiatives. These actions are designed to strengthen our competitive position and set the stage for improved growth and profitability over the medium term. With that, I hand it over to our CFO and an in-depth discussion of the figures. Christian, please. Thanks, Stephan. Good afternoon, ladies and gentlemen. Thank you for joining us today. I'm pleased to walk you through our financial performance for the year 2025. Over the past year, we saw increasing momentum in our PCT division, supported by stronger customer engagement and expanding demand across the semiconductor industry. During the year, our IXM innovations gained meaningful market traction with new wins and broader adoption. Near-term earnings were impacted as expected by targeted growth investments at IXS. These investments support our long-term strategy to reposition the division towards the semiconductor industry. As the year progressed, we delivered sequential margin improvements in the second half, reflecting higher volumes, improved execution, and operational efficiencies. Finally, we pushed ahead with the construction of the Penang site, which was fully funded from operating cash flow, demonstrating our ability to generate cash across the cycles. That brings us to a closer look at our financial results for 2025. Let me start with our performance in the first half of 2025. In H1, we delivered results that were significantly ahead of H1 2024, with revenue up more than 20% year-on-year. This strength was largely driven by PCT. As we moved into the second half, the external environment became more challenging. Increased macroeconomic and geopolitical uncertainty drove greater caution in ordering patterns, particularly regarding the timing of orders and deliveries. As a result, we saw an atypical sales pattern with H2 revenue broadly in line with H1 2025, rather than the seasonal uplift we would normally expect. Despite this flatter revenue profile, we managed to improve profitability in the second half year. EBITDA margin increased by 2 percentage points to 11.1% compared with H1 2025. Market dynamics began to improve towards the end of the year. We saw stronger customer engagement and an improvement in order intake already in December. This momentum has continued into the first two months of financial year 2026. While we remain mindful of ongoing global uncertainty, these early indicators give us confidence and clear confidence as we enter the new fiscal year into the further development. Let's now take a closer look at divisional performance. Before I do, one brief remark that applies to all divisions. Our operational performance is not fully reflected in the reported figures. Across all divisions, results were impacted by currency effects ranging from more than 5% in PCT to almost 4% in IXM and over 3% in the IXS division. This was driven by the weakness of the US dollar against the Swiss franc, more than any other currency development. Let me turn back to the performance of our divisions. PCT achieved a growth of 3.9% in Swiss franc and close to 10% in local currency. From a margin perspective, mix effects played an important role. These were not limited to the product mix in PCT, where we sold a higher proportion of lower margin products, but also extended to the regional and country mix, which developed unfavorably during the year 2025. As a result of these mix and foreign exchange effects, gross margin came in lower year-on-year, this translated into a lower EBITDA margin of 15.7% compared to 20.4% in previous year. Turning to IXS, we continue to invest decisively into the future, which is reflected in a still negative EBITDA margin of -6.8% in 2025. The progress we are making with the new CA20 system, specially designed for semiconductor market, is truly encouraging. Developing the market and increasing market penetration require ongoing and substantial investment into development and marketing. We invested a double-digit million CHF amount in 2025, committed the same amount also for 2026. We expect to break even for CA20 at the latest in 2028. IXM, on the other hand, delivered a very solid performance. We achieved 4.8% net sales growth in CHF and 8.7% in local currencies. Alongside with a margin expansion from 15.4%-15.9%. The better margin was supported by the division's strong positioning with new products for growth industries such as semiconductors, combined with a continued focus on cost efficiency. Beyond this, IXM also successfully managed to limit the impact of U.S. tariffs and foreign exchange effects on its results. From a regional perspective, most regions continued to grow sales except North America and China. China, however, remains at a high absolute level. What we are seeing there is less a structural weakness and more a phase of consolidation as the market digests the exceptionally strong growth rates of the past few years. In IXS and IXM, the lower sales figures in China primarily reflect portfolio actions. We exited selected less profitable activities, which were clearly the right decision from a value creation perspective. I will now turn to the group's financial performance in the financial year 2025. Net sales increased by 2.6% in CHF and 7.3% in constant currencies, reflecting resilient underlying demand across the group, as well as the impact from adverse foreign exchange developments, mainly from the weaker US dollar. The gross profit margin of 38% in 2025 compares to 42.8% in the prior year. The decline in gross margin was primarily driven by negative effects, as well as an unfavorable product and regional sales mix in PCT. These factors more than offset the benefits from operational efficiencies which we were able to realize in the year 2025. EBITDA totaled CHF 46.3 million, with an EBITDA margin of 10.1%, down from 13% in the full year 2024. The year-on-year decrease in EBITDA margin was mainly attributable to the lower gross profits, while operating expenses remained broadly stable. Net income amounted to CHF 12.2 million after CHF 32.8 million in the prior year. The overproportional decrease is reflecting changes in the recognition of deferred tax assets as well as negative impact of XF movements in the financial results. Turning to shareholder returns, we propose a dividend of CHF 0.5 per share, representing a payout ratio of 31.9%. Let me take you through the free cash flow development. In 2025, we significantly increased our CapEx to CHF 42.5 million, or 9.3% of sales, compared to the only CHF 12.8 million or 2.9% in 2024. The main elements contributing to the higher CapEx were the new fully owned site in Penang, as well as the new clean room facility in Flamatt for IXM. These projects are foundational investments that strengthen our operational capabilities, expand capacity, and support future revenue growth and cost improvements. Despite these elevated levels of CapEx, we achieved a positive free cash flow of CHF 8.5 million for the year. This reflects the strength of our operating cash flow and enables us to fund growth investments organically without compromising financial flexibility or without increasing leverage. As a result, our balance sheet remains very robust. We continue to operate with a conservative leverage profile and net cash positive at CHF 5.3 million, and hold a strong cash position of nearly CHF 100 million in cash and cash equivalents. While progress in 2025 was meaningful, it re-represents only the first phase of what we believe is possible. We will continue to emphasize growth and profitability. What has become clearer is that we have multiple levers at our disposal to further improve both profitability and sustainable growth. This year, we are actively pulling those levers. A central pillar of our approach is cost reduction and efficiency improvements implemented across the entire organization. This is not about short-term fixes. It's about structurally improving how we operate. We have identified the key success factors that matter most, we are now focused on addressing them decisively and consistently by moving from identification to measures to execution. All of this is happening against the backdrop of a business environment that has changed dramatically over the past few years. Volatility, inflationary pressure, and shifting customer expectations require us to cautiously and continuously adapt. This transformation is also an opportunity. An opportunity to streamline our organization and to critically reflect on what we do, how we do it, and where there are better ways or more effective ways of delivering what we need to deliver. At the core of our decision-making is a fundamental question: Are we prioritizing investments that maximize impact towards our strategic objectives for growth and profitability? That question guides our capital allocation, our operating decisions, and our priorities as a management team. That said, developing Comet in this direction will also be reflected on our 2026 performance. First, our cost reduction and efficiency program. This program is not short-term cost-cutting exercise. It addresses both strategic and operational dimensions of the business and the Group. We focus on reducing costs while increasing return on investment through disciplined resource allocation and through structural analysis and measures we are taking in the company. Importantly, related costs will be predominantly expensed in 2026. The investments will impact EBITDA by approximately 1.5 percentage points in this year. The benefits are sustainable. From 2027 onwards, we expect the recurring revenue gains to very clearly exceed the investments made in 2026, creating a clear net positive contribution to our earnings. Major development is the Penang ramp-up, executed as a controlled dual-site transition. Throughout the ramp-up phase, we will maintain our existing operations to protect revenue streams and service levels. This will result in a time-bound overlap in 2026. With this, that will reduce EBITDA margin by an additional 1.5 percentage points in the year. It is a conscious decision to de-risk with execution and to prepare for future development and cost improvements. Taken together, these two initiatives explain why the reported EBITDA in 2026 includes transition-related one-off costs. For this reason, we are guiding 2026 on adjusted EBITDA, which better reflects the underlying operating performance of the business. To conclude and summarize, Comet stands at a clear inflection point. At TCT, we are seeing new product revenues beginning to meaningful contribute to results, and we see the ramp-up to take shape. At IXS, the strategic transition into semiconductors continues to make promising progress. While this transition temporarily weighs on margins, it is deliberate and value-accreditive. IXM delivered solid growth driven by new products and continued expansion into new markets. This growth was achieved despite a challenging external environment. Across Comet, we are laying the foundation for sustainably higher profitability. Our cost reduction and efficiency improvement program is being executed in 2026 and is designed to structurally improve margins, capabilities, and so forth for the whole company. Finally, we are leveraging our new Asian site in Penang to scale production, optimize our cost base, and further strengthen business resilience. The main CapEx for the site will be spent until the end of 2026. From financial perspective, the investments and the transition underway lay the foundation for long-term value creation. With that, I conclude my review of 2025 then hand it back to our CEO for an outlook on 2026. Stephan, please. Thank you, Christian. Let me turn to our journey ahead. There you go. Before I talk about our outlook for 2026, let me take a moment to share a few thoughts on how we further developed our strategy last year with a focus on 2030 and the direction we're heading. I want to be very clear about one thing from the outset. This is not a change of direction. It is a consequent evolution of a strategy we set in motion in 2019. In 2019, we made a clear choice. We decided to focus our company on semiconductor-led growth, sharpen our portfolio around core technologies, expand decisively in Asia while maintaining a strong global R&D backbone, and improve execution discipline through the Boost program. That strategy has guided our decisions over the past years. What you see today is an evolution of that strategy. It's logical continuation. Over time, markets and customer needs evolve, and scale creates new opportunities. First, we are moving from a semiconductor-led growth focus to an all-in semiconductor approach. This reflects the central role semiconductors now play across industries and our conviction that this is where our strongest long-term value creation lies. Second, we are leveraging our core competencies more deeply. Rather than spreading ourselves thin, we are expanding into complementary domains where our existing technologies, know-how, and customer relationships give us a clear right to win. This allows us to broaden our relevance along the value chain while maintaining focus. Third, our geographic strategy is also evolving. Our earlier Asia expansion created a strong foundation. With the new site in Penang and our localization plans in Asia, we will be closer to customers, improve resilience, and enhance cost competitiveness while continuing to rely on and expand our global R&D backbone. Fourth, execution remains a priority. The Boost program was about discipline and delivery. Building on that experience, we are now rolling out a cost savings and efficiency program designed to structurally improve margins and scalability without compromising innovation or growth. All these elements point in the same direction. They are not isolated initiatives, they are connected steps along one strategic path. This path leads us to 2030 with the intermediate financial goals we set until the next peak of the semiconductor cycle currently expected to happen in 2028. Now, let me start with the headline message that frames our outlook. Wafer fab equipment spend is set to accelerate in 2026, and momentum in other industrial markets is improving. First, semiconductors. The positive trend in the semiconductor and electronics industry is continuing and strengthening. What we are seeing today is not just a cyclical rebound, but a stronger than anticipated ramp, driven by capacity constraints and shortages across several segments, including NAND. These shortages are accelerating customer investment decisions and pulling spending forward. As a result, the outlook for the semiconductor industry in 2026 is becoming increasingly bullish. While Q1 will follow the usual seasonal pattern with a slower start to the year, the underlying trend is clearly upward, and momentum builds steadily as we move through the year. This is reflected in wafer fab equipment spending expectations for fiscal year 2026, which are expected in the range of $122 billion-$135 billion, representing growth of roughly 10%-20% year-on-year. That is a meaningful acceleration compared to 2025, and it supports our conviction that staying all in on semiconductors is the right strategic choice. Secondly, we expect momentum to improve across other industrial segments in 2026. In aerospace, sustained air traffic growth is translating into higher demand across the supply chain. In defense, spending remains structurally strong, supported by long-term geopolitical realities rather than short-term cycles. In automotive, overall vehicle production is broadly flat. However, the picture is improving. Traditional volumes are stabilizing, and importantly, EV demand is showing early recovery signals after a challenging period. Of course, we remain realistic. Trade and tariff risks have not disappeared. They continue to add cost, complexity, and volatility to the system, which often cannot but be absorbed by ourselves. However, our focus on operational efficiency, regionalization, and disciplined cost management will allow us to absorb volatility and negative impacts while continuing to invest in growth. As we look into 2026, the outlook for our industry is constructive, and our confidence is building. We see accelerating semiconductor demand within a sustained growth cycle, supported by structural drivers across multiple end markets. Importantly, the recovery is broadening. Memory CapEx is returning alongside continued strength in logic applications. Operationally, higher utilization rates and a favorable mix shift are beginning to support margin expansion. Order momentum is building as we speak, particularly as we move into the second half of the year. At the same time, we remain mindful that volatility remains elevated, both macroeconomically and geopolitically. Our approach is therefore balanced. We are positioned for growth while maintaining discipline and flexibility. Against this backdrop, our focus for the year ahead is clear. We are driving the commercialization of next-generation product platforms, ensuring that innovation translates into revenue. We are scaling our Asia footprint and deepening local capabilities to stay close to our customers and strengthen our role in the value chain. We are enhancing transparency while sharpening our cost and profitability focus. This brings me to the guidance for 2026. While we are confident that net sales in 2026 and the adjusted EBITDA margin will significantly exceed 2025, that means excluding one-off items of roughly 3 percentage points will improve year-over-year. We are not providing quantitative guidance today. The semiconductor cycle is beginning to turn, and while volatility remains, visibility is only gradually improving. As the year progresses, we expect visibility to continue to improve and intend to provide more quantitative guidance. Overall, our outlook reflects strong confidence in accelerating growth and a meaningful improvement in profitability as we move toward our peak of cycle targets. With these final remarks, I conclude my presentation, and I would like to thank you for your attention and now open the floor for questions. You're back, Uli. Thank you, Stephan. Thank you, Christian, for the speech. We start with questions here in the room. Those who follow us via webcast or conference call will have the opportunity to ask questions later on. Before we start, a few remarks. First, wait for a microphone that will be distributed by my colleague. State your name and your company, and if possible, limit your question to two. Thank you. First comes from Michael Voigt. Thank you. Michael from Vontobel. Two questions. The first one is given that you're not guiding quantitatively, it would be helpful to have an understanding of the order trend in Q4, and also maybe some indication on where the book-to-bill is standing currently after two months. That would be the first one to really help us understand how the dynamics are looking. The second one would be if you can give some indications on, you know, what you mean by all-in semiconductor. What are the consequences for the businesses that are not related to the semiconductor industry? Thank you. Okay. Let's start with the question on the order trend and the book-to-bill ratios. When we look into the full year 2025, that was somehow below one. If we look into the Q4, it was nearly exactly one. If we look into what we expect for the first quarter, we said it will be clearly above one, and that's what we see in the first two month already, and we see that development continuing. We can see in the numbers as well as in what's behind the numbers and ahead of the numbers, we can see the pickup. Huh? I think that's in terms of book-to-bills, what we, what we see, what we expect, and where we are coming from when we say we expect the book-to-bill clearly above 1 in Q1 and how it translates or it's put into context of coming slowly starting Q4 with a pickup and then much stronger in Q1. Second question? Second question. Thank you, Michael. What does all-in mean for us? That is kinda a layered cake. Starts perhaps with how we spend our R&D money, which is very sizable when you look at the functional cost block of our P&L. We spend very high amounts in R&D. All-in in semi means we only spend on semi products and product platforms. Over the past five years, we still had parts of the R&D pot being used for non-semi or maybe near semi applications. That is one aspect of all-in. Another aspect of all-in is that we are deliberately discontinuing products that are non-semi-related, even up to the point where we may look into divesting certain activities. Hope that gives some color to your question. Cool. Michael Ihnen from ZKB. Two questions. You say 300 basis points on the EBITDA margin, but obviously your margin is, you know, 10% in 2025. We're expecting it to be much higher in 2026. Maybe you can give us a bit of an guidance on absolute terms. I mean, how much is it really? If your EBITDA moves up strongly, it's much higher obviously than when I calculate with 10%. Just to understand what are we talking about here in absolute terms, at least a little bit as the first one. Okay. Let's go to the first question first. Look, there's a reason why we are giving the guidance we are giving, and the reason is basically the main driver for our profitability is volume. In volume we see the very clear signs, as just described, for the uptick and for the start, for the beginning ramp. Where we have less knowledge, let's put it that way, is how fast and how steep. If you imagine the curve and you don't know which quarter it starts to really take a steeper turn, and you have 1 year or 4 quarters. If that's a quarter earlier or later makes a huge difference. That's the reason we know it's gonna be very good. We just don't know how good. That's the reason we don't guide the sales numbers quantitatively because it would be very broad band, and consequently, it doesn't make too much sense to talk about the EBITDA because what's driving the EBITDA in the end is the volume. Jut a follow-up. How can you then say it costs you 300 basis points of the EBITDA margin? Well, that I can very easily say because I know more or less what the expected cost range for our efficiency program is. We know this is a program we are doing together with a consultancy, a major consultancy. It's a structured program, and it goes across the whole group. We know plus minus what we will spend there. We have an estimate, but we'll have an other related cost in order to achieve the savings to be somehow precise. With that, I have an estimate what this might cost us. I know this is plus minus 1.5 basis points. In Penang, I know what type of costs we expect for the Penang ramp up, and that is cost which include scrap material while we have a qualification process for our vacuum capacitor manufacturing there. That includes that we have the two facilities, that includes moving, that includes a couple of project costs and so on. We know more or less what cost elements we have. As we know the cost elements, we know the how many percentage points that will more or less be. Maybe I can add. We are pretty precise there, huh? Maybe I can add a little color to it. I mean, the forecasts that we see, as I mentioned, earlier today, in unit volumes is something I haven't seen in my role, up to date. As you also know, the leverage that we have on volume is rather strong, steep. Yep. The outcome can vary, not violently, but strongly, depending on when we reach peak volume this year. If we reach peak volume at all this year. We're putting ourselves on the side of caution rather than trying to give you a broad band that definitely covers it. We do not want to sandbag either. This didn't count as my second question. Well, that you have another chance to take the third one. Thank you. The third one actually is just on the new product, Synertia and CA20 together. I mean, Synertia, just trying to figure out if you had more high volumes order than you announced at the CMD and with the CA, because there was a slide where you show it. CA20, do I see the revenues already in IXS? Because in H2, you had a pretty huge jump in revenues in IXS versus H1. The answer to the first part of the question is yes. The answer to the second part of the question is we are booking revenue for CA20 as we speak. Whereas we had predominantly order intake most of all in the last quarter of 2025. This is now turning into revenue as we speak, while further orders are coming in. Thank you, Michael, for your questions. Do we have another question in the room? If not, do we have any questions from the conference call? Sir, so far there are no questions from the phone. Okay. Feel free to ask question. We have ample time to answer those. If you wanna do that over a fresh coffee. Good. If there are no questions in the room, if there are no questions in the conference call, then we can invite you to a coffee and some very small snacks. Thank you for coming over. Looking forward to continue the dialogue with you. Have a good rest of the day and a good weekend. Thank you. Ladies and gentlemen, the conference is now over. Thank you for choosing Chorus Call, and thank you for participating in the conference. You may now disconnect the lines. Goodbye.